www.fdanews.com/articles/113901-fda-grants-orphan-drug-designation-to-chemgenex-8217-s-omacetaxine
FDA Grants Orphan Drug Designation to ChemGenex’s Omacetaxine
January 20, 2009
ChemGenex Pharmaceuticals Limited announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug designation to omacetaxine for the treatment of Myelodysplastic Syndromes (MDS).
The Earth Times
The Earth Times